REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO Inc. (RGNX) will participate in two upcoming investor conferences: the Stifel 2023 Healthcare Conference on November 14, 2023, and the Piper Sandler 35th Annual Healthcare Conference on November 29, 2023, both in New York, NY. The fireside chats will be live webcasted and available for replay on the company's website.

ROCKVILLE, Md., Nov. 7, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate the following upcoming investor conferences:

Stifel 2023 Healthcare Conference 
Fireside Chat Date: Tuesday, November 14, 2023
Fireside Chat Time: 3:00 p.m. ET
Location: New York, NY

Piper Sandler 35^th Annual Healthcare Conference 
Fireside Chat Date: Wednesday, November 29, 2023
Fireside Chat Time: 12:30 p.m. ET
Location: New York, NY

A live webcast of the fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8 and AAV9. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates, including late-stage and commercial programs, in multiple therapeutic areas. REGENXBIO is committed to a "5x'25" strategy to progress five AAV Therapeutics from our internal pipeline and licensed programs into pivotal-stage or commercial products by 2025.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
Chris Brinzey, ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301979626.html

SOURCE REGENXBIO Inc.

FAQ

What is the ticker symbol of REGENXBIO Inc.?

The ticker symbol of REGENXBIO Inc. is RGNX.

When and where will the fireside chat at the Stifel 2023 Healthcare Conference take place?

The fireside chat at the Stifel 2023 Healthcare Conference will take place on Tuesday, November 14, 2023, in New York, NY.

Where can I access the live webcast of the fireside chats?

The live webcast of the fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com.

For how long will the archived replay of the webcast be available?

The archived replay of the webcast will be available for approximately 30 days following the presentation.